136 related articles for article (PubMed ID: 20602718)
1. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
[TBL] [Abstract][Full Text] [Related]
2. Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments.
Chen S; Wu N; Fraser K; Boulanger L; Zhao Y
Curr Med Res Opin; 2010 Oct; 26(10):2507-16. PubMed ID: 20831456
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
Zhao Y; Sun P; Watson P
Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
[TBL] [Abstract][Full Text] [Related]
4. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
[TBL] [Abstract][Full Text] [Related]
5. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
O'Connor AB
J Pain; 2006 Nov; 7(11):867; author reply 867-8. PubMed ID: 17074629
[No Abstract] [Full Text] [Related]
7. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
Skljarevski V; Desaiah D; Zhang Q; Chappell AS; Detke MJ; Gross JL; Ziegler D
Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
[TBL] [Abstract][Full Text] [Related]
9. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine (Cymbalta) for diabetic neuropathic pain.
Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
Gao Y; Ning G; Jia WP; Zhou ZG; Xu ZR; Liu ZM; Liu C; Ma JH; Li Q; Cheng LL; Wen CY; Zhang SY; Zhang Q; Desaiah D; Skljarevski V
Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
[TBL] [Abstract][Full Text] [Related]
13. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
[TBL] [Abstract][Full Text] [Related]
14. Diabetic peripheral neuropathic pain: recognition and management.
Cole BE
Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
[TBL] [Abstract][Full Text] [Related]
15. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
[TBL] [Abstract][Full Text] [Related]
16. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall JA; Risser RC; Gonzales JS
Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
[TBL] [Abstract][Full Text] [Related]
17. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
Russell JW
Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
[No Abstract] [Full Text] [Related]
18. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Hall JA; Wang F; Oakes TM; Utterback BG; Crucitti A; Acharya N
Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
